Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 56c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.32), $0.56 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Take-Two stock drops as GTA 6 leaks continue
• DoW signs deals with General Dynamics, Lockheed to boost missile output
• Credo Tech (CRDO) call put ratio 1 call to 1.3 puts into quarter results